An interventional study of Stellate gangalion block in Mastectomy, Pain, Acute and Pain, Chronic, sponsored by Mansoura University. Recruiting at 1 site in Egypt. Open to female participants aged 21 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-02-17.
Sponsored by Mansoura University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 40 studies in Acute Pain with a site in Egypt — 6 open to participants now, 6 under way, none of them phase 3. Acute Pain · Egypt.
Among the 40 studies in Acute Pain with a site in Egypt, this one is the 4th largest by planned enrollment, is one of 3 that started in 2024, is one of 28 with no phase, and was the 35th registered.
1,077 studies on the registry are indexed under Acute Pain; 168 are open to participants now.
Browse Acute Pain studies →6 of the 40 studies in Acute Pain with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 20–60 · Healthy volunteers
Al-Azhar University · Sites in Egypt
Ages 21–35 · Women only
South Egypt Cancer Institute · Sites in Egypt
Ages 18–70
Assiut University · Sites in Egypt
Ages 18–50
Mansoura University · Sites in Egypt
Ages 6–12
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 103 Acute Pain studies recruiting now, 40 (39%) set no upper age limit and 50 (49%) stop at 75 or younger; 21 take children under 18; 24 take healthy volunteers.
This study: 21 Years to 65 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
40 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 8 · Phase 3 4 · Phase 4 3
First in 2007; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 140 is above the median of 86 across 905 interventional studies indexed under Acute Pain.
Median enrollment 77 across the 40 interventional studies. Of the 24 that completed or were terminated, 1 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 40 have an industry lead sponsor. The 10 most frequent:
Mansoura University is the lead sponsor of 1,121 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Mansoura University has 3 studies filed under Acute Pain — fewer than ten, so there is no comparison to draw.
2 of the studies in Acute Pain with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05750992Al-Azhar UniversityUltrasound Guided TAPB vs Surgical TAPB With Bupivacaine in Cesarean Section | 2026-12-30 |
| NCT06263907Mansoura UniversityStellate Ganglion Block for Prevention of Post Mastectomy Depression | 2027-11-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 40 studies in Acute Pain with a site in Egypt, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Complications after mastectomy include chronic pain and depression.
A mastectomy is surgery could be associated with complications include chronic pain and depression. In female breast cancer patients, the incidence of postoperative depression was 46.55%. Stellate ganglion block had been used for treating post-traumatic stress disorder (PTSD) and depression symptoms even in its prevention. Also, it used in treatment of chronic pain.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will receive ipsilateral stellate gangalion block (4ml) bupivacaine 0.25 %+( 4ml) normal saline + (8mg) dexamethasone in a total 10 ml
Procedure: Stellate gangalion block
Patients will not receive stellate gangalion block
The efficacy of Preoperative ipsilateral stellate gangalion block on the occurrence of postmastectomy depression and pain compared with no block
incidence of postmastectomy depression
Beck Depression Inventory (BDI) score
Time frame: 6 months postoperatively
incidence of postmastectomy depression
Beck Depression Inventory (BDI) score
Time frame: 3 months postoperatively
the need for postoperative antidepressant
needed or not
Time frame: during the first 6 months postoperatively
acute postoperative pain at the incision site (breast and the axilla)
Numerical rating scale (NRS) (0-10)
Time frame: every 12 hour for the first 48 hour recorded
chronic postmastectomy pain at the incision site
Numerical rating scale (NRS) (0-10)
Time frame: at 3 and 6 months postoperatively
incidence of nausea and vomiting
occurred or not
Time frame: during first 3 postoperative days
Functional pain in the ipsilateral shoulder
extended from the shoulder to the elbow or to the hand either associated with swelling, changing in the colour or temperature of that limb or associated with reduction in the range of the movement (elbow extension or arm abduction or fixed flexion deformity
Time frame: during the first 6 months postoperatively
Any complications related to stellate ganglion injection
local hematoma, persistent postoperative horner's syndrome or respiratory distress
Time frame: within 1 day postoperatively
Started Mar 2024 (actual). Primary completion is estimated for Nov 2027, 44 months after the start.
Of 425 non-industry interventional studies with no phase under Acute Pain, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 44 months is above that.
Counting every sponsor, half of 431 studies reached it within 11 months; a quarter within 5 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.